Vanguard Group’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.6M | Buy |
|
|||||
|
2025
Q1 | $24.4M | Buy |
|
|||||
|
2024
Q4 | $18M | Sell |
|
|||||
|
2024
Q3 | $12.5M | Buy |
|
|||||
|
2024
Q2 | $9.24M | Buy |
|
|||||
|
2024
Q1 | $10.6M | Hold |
|
|||||
|
2023
Q4 | $4.36M | Buy |
|
|||||
|
2023
Q3 | $4.44M | Hold |
|
|||||
|
2023
Q2 | $4.78M | Sell |
|
|||||
|
2023
Q1 | $4.79M | Buy |
|
|||||
|
2022
Q4 | $4.38M | Buy |
|
|||||
|
2022
Q3 | $2.74M | Buy |
|
|||||
|
2022
Q2 | $3.65M | Sell |
|
|||||
|
2022
Q1 | $6.84M | Buy |
|
|||||
|
2021
Q4 | $9.5M | Sell |
|
|||||
|
2021
Q3 | $16.5M | Buy |
|
|||||
|
2021
Q2 | $25.7M | Buy |
|
|||||
|
2021
Q1 | $21.9M | Sell |
|
|||||
|
2020
Q4 | $11.7M | Sell |
|
|||||
|
2020
Q3 | $9.87M | Buy |
|
|||||
|
2020
Q2 | $10.4M | Buy |
|
|||||
|
2020
Q1 | $7.19M | Buy |
|
|||||
|
2019
Q4 | $9M | Buy |
|
|||||
|
2019
Q3 | $7.43M | Buy |
|
|||||
|
2019
Q2 | $8.19M | Buy |
|
|||||
|
2019
Q1 | $7.38M | Buy |
|
|||||
|
2018
Q4 | $5.47M | Buy |
|
|||||
|
2018
Q3 | $6.74M | Buy |
|
|||||
|
2018
Q2 | $5.5M | Buy |
|
|||||
|
2018
Q1 | $5.22M | Buy |
|
|||||
|
2017
Q4 | $5.93M | Buy |
|
|||||
|
2017
Q3 | $4.21M | Buy |
|
|||||
|
2017
Q2 | $3.42M | Sell |
|
|||||
|
2017
Q1 | $2.65M | Buy |
|
|||||
|
2016
Q4 | $3.13M | Buy |
|
|||||
|
2016
Q3 | $2.79M | Buy |
|
|||||
|
2016
Q2 | $3.74M | Buy |
|